ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,236.80
1.52%
Dow Jones
38,239.66
0.40%
Brent Oil
88.155
0.01%
Bitcoin
63,897.36
-0.91%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Hvivo Plc (HVO) Quote

Hvivo Plc

Hvivo Plc (HVO)

LSE
28.25
-0.35
(-1.22%)
Closed April 26 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
28.25
Bid
28.00
Ask
28.50
Volume
657,832
28.25 Day's Range 28.50
14.15 52 Week Range 31.00
Market Cap
190.709M
Previous Close
28.60
Open
28.50
Last Trade
178
@
28.5
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,294,611
Shares Outstanding
675,075,857
Dividend Yield
-
PE Ratio
-256.82
Earnings Per Share (EPS)
-0
Revenue
48.48M
Net Profit
-776k

About Hvivo Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.hvivo.com
Headquarters
London, Gbr
Founded
1970
Hvivo Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HVO. The last closing price for Hvivo was 28.60p. Over the last year, Hvivo shares have traded in a share price range of 14.15p to 31.00p.

Hvivo currently has 675,075,857 shares outstanding. The market capitalization of Hvivo is £190.71 million. Hvivo has a price to earnings ratio (PE ratio) of -256.82.

HVO Latest News

More News

hVIVO PLC Annual Report & Notice of AGM

hVIVO PLC 15 April 2024   hVIVO plc ("hVIVO" or the "Company")   Annual Report & Notice of AGM   hVIVO plc (AIM & Euronext: HVO), a rapidly growing specialist contract research...

April 15 2024
RNS Regulatory News

hVIVO swings to profit and commences annual dividends as outlook rosy

hVIVO PLC on Tuesday launched an annual dividend policy, as it swung to profit on the back of higher revenue and a ta ...

April 09 2024
Alliance News

hVIVO PLC Final results

hVIVO PLC 09 April 2024   hVIVO plc ("hVIVO", the "Company" or the "Group")   Final results  A record year across all financial and operational metrics On track to deliver future growth...

April 09 2024
RNS Regulatory News

hVIVO PLC Notice of Results

hVIVO PLC 27 March 2024     27 March 2024   hVIVO plc ("hVIVO", the "Company" or the "Group")   Notice of results   hVIVO plc (AIM & Euronext: HVO), a rapidly growing specialist contract...

March 27 2024
RNS Regulatory News

hVIVO PLC Holding(s) in Company

hVIVO PLC 22 March 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B9275X97 Issuer Name hVIVO plc UK or Non-UK Issuer UK 2. Reason for Notification An...

March 22 2024
RNS Regulatory News

hVIVO PLC Holding(s) in Company

hVIVO PLC 14 March 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B9275X97 Issuer Name hVIVO PLC UK or Non-UK Issuer UK 2. Reason for Notification An...

March 14 2024
RNS Regulatory News

hVIVO PLC Long Term Incentive Plan / PDMR Notification

hVIVO PLC 15 February 2024   hVIVO plc ("hVIVO" or the "Company")   Long Term Incentive Plan / PDMR Notification    hVIVO plc (AIM & Euronext: HVO), a rapidly growing specialist contract...

February 15 2024
RNS Regulatory News

IN BRIEF: hVIVO Chair and non-exec director sell 30.0 million shares

n-based contract research organisation testing vaccines for infectious and respiratory diseases - Confirms two shareho ...

February 14 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
113.6697247706427.2528.7526.25195836127.82027682DE
4-0.75-2.586206896552930.0526.25210024428.68743261DE
12-1.1-3.7478705281129.353124.75329461127.95941845DE
269.147.519582245419.153117.75297678226.04678616DE
5210.7561.428571428617.53114.15229961723.17644735DE
156-12.25-30.246913580240.542.58.565210790520.83012056DE
26025.6966.0377358492.6547.252.55274398218.11131155DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FLJFLJ Group Limited
$ 0.72
(30.91%)
893.75k
IVPInspire Veterinary Partners Inc
$ 0.0487
(13.26%)
7.09M
BJDXBluejay Diagnostics Inc
$ 0.715
(11.39%)
505.95k
NUKKNukkleus Inc
$ 0.97
(9.98%)
105
HTLFHeartland Financial USA Inc
$ 38.93
(9.05%)
15.12k
CACOCaravelle International Group
$ 0.8125
(-18.75%)
86.73k
IMTEIntergrated Media Technology Ltd
$ 2.1115
(-11.65%)
585
OLBOLB Group Inc
$ 0.32
(-11.41%)
26.64k
FCUVFocus Universal Inc
$ 0.287
(-10.68%)
158.18k
AWINAERWINS Technologies Inc
$ 2.85
(-8.95%)
10.32k
IVPInspire Veterinary Partners Inc
$ 0.0487
(13.26%)
7.09M
SQQQProShares UltraPro Short QQQ
$ 11.44
(0.00%)
2M
BRSHBruush Oral Care Inc
$ 0.062
(5.08%)
1.4M
AAPLApple Inc
$ 169.34
(0.03%)
1.04M
PEGYPineapple Energy Inc
$ 0.0632
(-3.51%)
995.26k

Discussion

View Full Feed
CincinnatiKid1 CincinnatiKid1 2 minutes ago
Closed at .001… the buy low sell high concept eludes some people … especially weirdo bashers who live on ihub.
VNUE
Poo28 Poo28 2 minutes ago
It is clear you are using yet another multiple monikers—Let’s see as TopFuel are you IM, JM or SB? The man-child cabal of bashers .

All from extract posted by Jet years ago  from Enforcement paperwork in which certain extracts included  posted in a filing . DBMM used it as example of
DBMM
burner67 burner67 3 minutes ago
So far nobody wants it
BEGI
Turbomunkey Turbomunkey 3 minutes ago
Enjoy the weekend all. Hopefully something something.
RXMD
gladeshawk gladeshawk 3 minutes ago
AIRI>>>> Performing like predicted. $20 will be a "given". $30.00 or more with new submarine contracts.
AIRI
WALLnut WALLnut 3 minutes ago
Why did it go up without a new catalyst?




RDGL
RDGL
ALDRADJKD123 ALDRADJKD123 4 minutes ago
Guess you’d rather grab a “woman” by her nads……LMFAOOOOOO

That explains that….
DJT
VeronicaFox VeronicaFox 4 minutes ago
As in the case of KEGS, No regulator says that. None, Zero, Zilch.

Btw, there are problems with your “dividend” scenario:

* KEGS has NO Short interest
* KEGS has NO dividend
* KEGS has NO Safe Harbor protection
* KEGS financials claimed:
KEGS
Longstrongsilver Longstrongsilver 4 minutes ago
There’s that lack of comprehension again Trigger (my new name for you ). Never said it was good or bad to trade. Never said it would go down or up. All I said is based off fundamentals this couldn’t possibly be worth more than $1 or $2 (based on shares out vs revs Vs costs Vs potential for growth).
DJT
Helter Skelter Helter Skelter 4 minutes ago
Who is this guy? 😺

https://european-wellness.eu/advisory/prof-dr-mike-chan/

$NIVF
NIVF
burner67 burner67 4 minutes ago
PFFFFF AHAHAHA. It might be up this week but it's down 84% from it's 52 week high lolol
B E G I
2 0 2 4
Bearish 💩💩💩💩💩
BEGI
r622102675 r622102675 5 minutes ago
That’s why the Mets didn’t sign Montgomery I guess…lol…r
CDMO
Stern is Bald Stern is Bald 5 minutes ago
Is English your 2nd language? I have no idea what type of an argument you are even trying to make but if English is your 2nd language id understand…

Listen to the questions the SC justices are asking Trumps lawyers… by not actually doing that you do yourself a disservice by not being
FNMA
sspalmo sspalmo 5 minutes ago
I don't remember Harry having any involvement with Clone 3 or 7. I thought the development of Clone 3 and 7 was on Joseph and maybe partially on Chandra. I do believe that SAGA thinks that they bought the rights to the technology by purchasing the subs. I don't believe that a transaction has been
ENZC
Backstabbed Backstabbed 5 minutes ago
Trade the trade. Company has good revenue. And market cap is stupid low
GXXM
jimr1717 jimr1717 5 minutes ago
🏆️ IFUS DD Updated >>, Marc Walther was found liable in a securities fraud lawsuit...

Complaint:
https://drive.google.com/file/d/1Wpk0lRCJaTOI3dmR_BeSNw6eWtnTt71s/view

Judgement: $397,744.50
https://drive.google.com/file/d/1nZjmmsmCwJlFwm9TR6NvokHH
HGYN IFUS
ksquared ksquared 5 minutes ago
Good one, cap. I miss those days, too.
Hope life is going well for you.
HGilS HGilS 6 minutes ago
Goat land is an abstract place.
ELTP
monocle monocle 6 minutes ago
I'm not offering anyone advice, just providing my opinion.

It's true that he could open a new one, but Mark closed his line of credit last year with money from Yorkville. $4 million tacked on to the 11 million borrowed to pay for that horror show of a merger. They would have paid tha
NB
eb0783 eb0783 6 minutes ago
That would be the infamous Steve A. Cohen..........

Steven A. Cohen is an American investor and hedge fund manager. He is the founder and CEO of Point72 Asset Management, a family office located in Stamford, Connecticut. As of April 2022, he has an estimated net worth of $17.4 billion
CDMO
Nrdc92 Nrdc92 6 minutes ago
No you idiot. They bought the shares for their index funds, shares of which are purchased by investors. They’re not out a dime.

The ignorance on this board is staggering.
LWLG
Nikodemos Nikodemos 7 minutes ago
Thank you for compiling this: Incredibly important & eye-opening! STUNNING even!

And, sorry to say,.... SAD!

TBH: Why my family & I left the U.S.. And, sadly, it does not appear to be getting any better!!


Sure hope that this is PART of the process
WesCrowe WesCrowe 7 minutes ago
So what would .0003's be Waterboy personality.
DKSC

Your Recent History

LSE
HVO
Hvivo
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved